J Nataf
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Blood groups and transfusion
- Immunology top 5%
- Biosimilars and Bioanalytical Methods
Papers in
-
- Blood groups and transfusion 7
- Genetics 6
- Blood disorders and treatments 4
- Chronic Lymphocytic Leukemia Research 4
- Hemoglobinopathies and Related Disorders 2
- Co-authors
- Valérie Ugo (3 shared papers)Irène Teyssandier (1 shared paper)Jean‐Jacques Kiladjian (1 shared paper)Bruno Varet (1 shared paper)Patrick A. Michaud (1 shared paper)T. Papo (1 shared paper)Nicole Casadevall (1 shared paper)B Viron (1 shared paper)
- Journals
- Transfusion (4 papers)Leukemia (2 papers)New England Journal of Medicine (1 paper)European Journal of Cancer (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- FranceMoroccoUnited States
In The Last Decade
J Nataf
14 papers receiving 1.2k citations
J Nataf's Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 420
- Immunology 533
- Genetics 225
- Hepatology 110
- Pharmacology 101
Countries citing papers authored by J Nataf
This map shows the geographic impact of J Nataf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Nataf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Nataf more than expected).
Fields of papers citing papers by J Nataf
This network shows the impact of papers produced by J Nataf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Nataf. The network helps show where J Nataf may publish in the future.
Co-authors
The 25 scholars most cited alongside J Nataf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin Hit paper breakdown → | 2002 | 843 |
| 2 | 1990 | 147 | |
| 3 | 2006 | 69 | |
| 4 | 1997 | 55 | |
| 5 | 1990 | 53 | |
| 6 | 2003 | 49 | |
| 7 | 2006 | 16 | |
| 8 | 2012 | 16 | |
| 9 | 2004 | 15 | |
| 10 | 2015 | 12 | |
| 11 | 2016 | 12 | |
| 12 | [Acute hepatitis caused by dihydralazine]. | 1987 | 6 |
| 13 | 2023 | 1 | |
| 14 | 2015 | 1 | |
| 15 | 2017 | 0 |
About J Nataf
J Nataf is a scholar working on Hematology, Genetics, Oncology, Genetics and Pathology and Forensic Medicine, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Blood groups and transfusion (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Blood disorders and treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (420 citations), Immunology (533 citations), Genetics (225 citations), Hepatology (110 citations) and Pharmacology (101 citations). J Nataf has collaborated with scholars based in France, Morocco and United States. Frequent co-authors include Valérie Ugo, Irène Teyssandier, Jean‐Jacques Kiladjian, Bruno Varet, Patrick A. Michaud, T. Papo, Nicole Casadevall, B Viron, Patrick Mayeux and P Martin-Dupont. Their work appears in journals such as Transfusion, Leukemia, New England Journal of Medicine, European Journal of Cancer and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.